β-Cell-selective regulation of gene expression by nitric oxide
Authors:
Open Access
- 1 June 2024
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Regulatory, Integrative and Comparative Physiology
- Vol. 326 (6) , R552-R566
Abstract
Nitric oxide is produced at low micromolar levels following the induction of inducible nitric oxide synthase (iNOS) and is responsible for mediating the inhibitory actions of cytokines on glucose-stimulated insulin secretion by islets of Langerhans. It is through the inhibition of mitochondrial oxidative metabolism, specifically aconitase and complex 4 of the electron transport chain, that nitric oxide inhibits insulin secretion. Nitric oxide also attenuates protein synthesis, induces DNA damage, activates DNA repair pathways, and stimulates stress responses (unfolded protein and heat shock) in β-cells. In this report, the time- and concentration-dependent effects of nitric oxide on the expression of 6 genes known to participate in the response of β-cells to this free radical were examined. The genes included Gadd45α (DNA repair), Puma (apoptosis), Hmox1 (antioxidant defense), Hsp70 (heat shock), Chop (UPR), and ßPpargc1α (mitochondrial biogenesis). We show that nitric oxide stimulates β-cell gene expression in a narrow concentration range of ~0.5-1 µM, or levels corresponding to iNOS-derived nitric oxide. At concentrations greater than 1 µM, nitric oxide fails to stimulate gene expression in β-cells, and this is associated with the inhibition of mitochondrial oxidative metabolism. This narrow concentration range of responses is β-cell selective, as the actions of nitric oxide in non-β-cells (α-cells, mouse embryonic fibroblasts, and macrophages) are concentration-dependent. Our findings suggest that β-cells respond to a narrow concentration range of nitric oxide that is consistent with the levels produced following iNOS induction, and that these concentration-dependent actions are selective for insulin-containing cells.Keywords
Funding Information
- HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK052194)
- HHS | NIH | National Institute of Allergy and Infectious Diseases (AI044458)
- JDRF (3-SRA-2023-1281-S-B)
This publication has 76 references indexed in Scilit:
- The pathogenic “symphony” in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreasCell Metabolism, 2023
- Can insulin secreting pancreatic β-cells provide novel insights into the metabolic regulation of the DNA damage response?Biochemical Pharmacology, 2020
- Sequential Changes in Serum Cytokines Reflect Viral RNA Kinetics in Target Organs of a Coxsackievirus B Infection in MiceJournal of Clinical Immunology, 2009
- Life in the balance: how BH3-only proteins induce apoptosisCurrent Opinion in Cell Biology, 2005
- The role of interleukin-1 in the pathogenesis of IDDMDiabetologia, 1996
- Reversible inhibition of cytochrome c oxidase, the terminal enzyme of the mitochondrial respiratory chain, by nitric oxideFEBS Letters, 1994
- Endogenous nitric oxide induced by interleukin‐1β in rat islets of Langerhans and HIT‐T15 cells causes significant DNA damage as measured by the ‘comet’ assayFEBS Letters, 1993
- Inhibition of insulin secretion by interleukin‐1β and tumour necrosis factor‐α via an L‐arginine‐dependent nitric oxide generating mechanismFEBS Letters, 1990
- Affinity-purified human Interleukin I is cytotoxic to isolated islets of LangerhansDiabetologia, 1986
- Pulsradiolytische Untersuchung der NO‐Oxydation und des Gleichgewichts N2O3 ⇄ NO + NO2 in wäßriger LösungBerichte der Bunsengesellschaft für physikalische Chemie, 1970